These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17558118)
21. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B; Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420 [TBL] [Abstract][Full Text] [Related]
22. The PROGRESS trial three years later: time for a balanced report of effectiveness. Wennberg R; Zimmermann C BMJ; 2004 Oct; 329(7472):968-70. PubMed ID: 15499116 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme. Pella D High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):107-13. PubMed ID: 21950782 [TBL] [Abstract][Full Text] [Related]
24. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee. J Hum Hypertens; 1998 Sep; 12(9):627-9. PubMed ID: 9783492 [TBL] [Abstract][Full Text] [Related]
25. Trials on blood pressure-lowering and secondary stroke prevention. Chalmers J Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902 [TBL] [Abstract][Full Text] [Related]
26. The PROGRESS trial three years later: time for more action, less distraction. Macmahon S; Neal B; Rodgers A; Chalmers J BMJ; 2004 Oct; 329(7472):970-1. PubMed ID: 15499117 [No Abstract] [Full Text] [Related]
27. Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial. Dézsi CA; Farsang C; Adv Ther; 2018 May; 35(5):644-654. PubMed ID: 29748913 [TBL] [Abstract][Full Text] [Related]
28. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. Dahlöf B; Gosse P; Guéret P; Dubourg O; de Simone G; Schmieder R; Karpov Y; García-Puig J; Matos L; De Leeuw PW; Degaute JP; Magometschnigg D; J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150 [TBL] [Abstract][Full Text] [Related]
29. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. Chalmers J; Neal B; MacMahon S; J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785 [TBL] [Abstract][Full Text] [Related]
30. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. Mourad JJ; Waeber B; Zannad F; Laville M; Duru G; Andréjak M; J Hypertens; 2004 Dec; 22(12):2379-86. PubMed ID: 15614033 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study. Holzgreve H; Risler T; Trenkwalder P Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588 [TBL] [Abstract][Full Text] [Related]
33. Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide. Myers MG; Asmar R; Leenen FH; Safar M J Hypertens; 2000 Mar; 18(3):317-25. PubMed ID: 10726719 [TBL] [Abstract][Full Text] [Related]
34. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee. J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716 [TBL] [Abstract][Full Text] [Related]
35. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats. You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090 [TBL] [Abstract][Full Text] [Related]
36. Progress in reducing the burden of stroke. Chalmers J; Chapman N Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323 [TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON]. Oganov RG; Nebieridze DV Kardiologiia; 2004; 44(3):66-9. PubMed ID: 15489830 [No Abstract] [Full Text] [Related]